This site was designed with the
.com
website builder. Create your website today.
Start Now

DARREN WOGMAN

Darren Wogman MSc

Get In Touch
  • Home

  • Research Pieces

  • Education

  • Skills

  • Recognitions

  • Privacy

  • More

    Use tab to navigate through the menu items.

    darren@wogman.com

    123-456-7890

    • All Posts
    • 101
    • Industry
    • Preclinical
    • Pharmacology
    • Toxicology
    • Clinical Studies
    • Clinical Development
    • Formulation Science
    • Clinical Pharmacology
    • Statistics and Data
    • Biologic and Advanced Therapies
    • Drug Safety & Ethics
    • Drug Regulatory Affairs
    Search
    Darren Wogman
    • May 25, 2021
    • 10 min

    Critique of Hamdy FC et al. N Engl J Med 2016; 375:1415-1424

    Critique of Hamdy FC et al. 10-year outcomes after monitoring, surgery or radiotherapy for localised prostate cancer. N Engl J Med 2016; 375

    98 views0 comments
    Darren Wogman
    • May 25, 2021
    • 10 min

    Clinical Trial Dataset Analysis - A phase 2a efficacy, safety and tolerability study

    Clinical Trial Dataset Analysis - A phase 2a efficacy, safety and tolerability study on treating patients with schizophrenia

    23 views0 comments
     

    Subscribe Form

    Thanks for submitting!

    • Facebook
    • Twitter
    • LinkedIn

    ©2021 by Darren Wogman. Proudly created with Wix.com